|
OPERATING BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION (Tables)
|
12 Months Ended |
|
Dec. 31, 2014
|
| Segment Information |
|
| Schedule of reportable business segment information |
|
Year Ended December 31,
|
|
2014
|
|
2013
|
|
2012
|
|
|
Net sales revenue:
|
|
|
|
|
|
|
|
|
NSP Americas
|
|
$
|
184,625
|
|
$
|
195,924
|
|
$
|
199,794
|
|
|
NSP Russia, Central and Eastern Europe
|
|
50,274
|
|
62,747
|
|
57,853
|
|
|
Synergy WorldWide
|
|
128,101
|
|
108,290
|
|
100,670
|
|
|
China and New Markets
|
|
3,367
|
|
2,865
|
|
2,509
|
|
|
Total net sales revenue
|
|
366,367
|
|
369,826
|
|
360,826
|
|
|
Contribution margin (1):
|
|
|
|
|
|
|
|
|
NSP Americas
|
|
75,673
|
|
80,095
|
|
80,324
|
|
|
NSP Russia, Central and Eastern Europe
|
|
17,851
|
|
22,542
|
|
21,957
|
|
|
Synergy WorldWide
|
|
43,888
|
|
38,011
|
|
36,142
|
|
|
China and New Markets
|
|
1,563
|
|
1,318
|
|
159
|
|
|
Total contribution margin
|
|
138,975
|
|
141,966
|
|
138,582
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
119,927
|
|
118,383
|
|
104,716
|
|
|
Operating income
|
|
19,048
|
|
23,583
|
|
33,866
|
|
|
|
|
|
|
|
|
|
|
|
Other income (loss), net
|
|
(34
|
)
|
1,993
|
|
1,573
|
|
|
Income from continuing operations before provision for income taxes
|
|
$
|
19,014
|
|
$
|
25,576
|
|
$
|
35,439
|
|
|
(1)
|
|
Contribution margin consists of net sales revenue less cost of sales and volume incentives expense.
|
|
Year Ended December 31,
|
|
2014
|
|
2013
|
|
2012
|
|
|
Capital expenditures:
|
|
|
|
|
|
|
|
|
NSP Americas
|
|
$
|
25,581
|
|
$
|
8,018
|
|
$
|
5,684
|
|
|
NSP Russia, Central and Eastern Europe
|
|
8
|
|
4
|
|
44
|
|
|
Synergy WorldWide
|
|
1,321
|
|
534
|
|
1,051
|
|
|
China and New Markets
|
|
—
|
|
—
|
|
—
|
|
|
Total capital expenditures
|
|
$
|
26,910
|
|
$
|
8,556
|
|
$
|
6,779
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization:
|
|
|
|
|
|
|
|
|
NSP Americas
|
|
$
|
3,438
|
|
$
|
3,568
|
|
$
|
3,339
|
|
|
NSP Russia, Central and Eastern Europe
|
|
25
|
|
27
|
|
36
|
|
|
Synergy WorldWide
|
|
946
|
|
871
|
|
703
|
|
|
China and New Markets
|
|
—
|
|
—
|
|
—
|
|
|
Total depreciation and amortization
|
|
$
|
4,409
|
|
$
|
4,466
|
|
$
|
4,078
|
|
|
As of December 31,
|
|
2014
|
|
2013
|
|
|
Assets:
|
|
|
|
|
|
|
NSP Americas
|
|
$
|
129,371
|
|
$
|
148,278
|
|
|
NSP Russia, Central and Eastern Europe
|
|
6,679
|
|
11,233
|
|
|
Synergy WorldWide
|
|
40,797
|
|
40,101
|
|
|
China and New Markets
|
|
19,952
|
|
—
|
|
|
Total assets
|
|
$
|
196,799
|
|
$
|
199,612
|
|
|
| Schedule of consolidated net sales revenue by geographical locations |
|
Year Ended December 31,
|
|
2014
|
|
2013
|
|
2012
|
|
|
Net sales revenue:
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
148,219
|
|
$
|
152,209
|
|
$
|
154,716
|
|
|
South Korea
|
|
54,314
|
|
34,207
|
|
28,006
|
|
|
Other
|
|
163,834
|
|
183,410
|
|
178,104
|
|
|
Total net sales revenue
|
|
$
|
366,367
|
|
$
|
369,826
|
|
$
|
360,826
|
|
|
| Schedule of revenue generated by each of the Company's product lines |
|
Year Ended December 31,
|
|
2014
|
|
2013
|
|
2012
|
|
|
NSP Americas:
|
|
|
|
|
|
|
|
|
General health
|
|
$
|
79,022
|
|
$
|
82,332
|
|
$
|
87,280
|
|
|
Immunity
|
|
23,881
|
|
24,013
|
|
24,410
|
|
|
Cardiovascular
|
|
12,665
|
|
13,268
|
|
13,483
|
|
|
Digestive
|
|
53,906
|
|
57,575
|
|
56,160
|
|
|
Personal care
|
|
4,025
|
|
5,214
|
|
5,792
|
|
|
Weight management
|
|
11,126
|
|
13,522
|
|
12,669
|
|
|
|
|
184,625
|
|
195,924
|
|
199,794
|
|
|
NSP Russia, Central and Eastern Europe:
|
|
|
|
|
|
|
|
|
General health
|
|
$
|
18,841
|
|
$
|
22,690
|
|
$
|
20,540
|
|
|
Immunity
|
|
6,512
|
|
7,902
|
|
7,365
|
|
|
Cardiovascular
|
|
3,104
|
|
4,324
|
|
4,367
|
|
|
Digestive
|
|
13,171
|
|
15,693
|
|
14,501
|
|
|
Personal care
|
|
6,073
|
|
8,817
|
|
8,908
|
|
|
Weight management
|
|
2,573
|
|
3,321
|
|
2,172
|
|
|
|
|
50,274
|
|
62,747
|
|
57,853
|
|
|
Synergy WorldWide:
|
|
|
|
|
|
|
|
|
General health
|
|
$
|
46,546
|
|
$
|
36,723
|
|
$
|
33,969
|
|
|
Immunity
|
|
974
|
|
1,394
|
|
1,104
|
|
|
Cardiovascular
|
|
42,449
|
|
42,154
|
|
42,696
|
|
|
Digestive
|
|
20,839
|
|
16,897
|
|
14,904
|
|
|
Personal care
|
|
7,196
|
|
7,097
|
|
5,631
|
|
|
Weight management
|
|
10,097
|
|
4,025
|
|
2,366
|
|
|
|
|
128,101
|
|
108,290
|
|
100,670
|
|
|
China and New Markets:
|
|
|
|
|
|
|
|
|
General health
|
|
$
|
1,566
|
|
$
|
1,306
|
|
$
|
1,180
|
|
|
Immunity
|
|
445
|
|
367
|
|
319
|
|
|
Cardiovascular
|
|
235
|
|
211
|
|
188
|
|
|
Digestive
|
|
835
|
|
726
|
|
632
|
|
|
Personal care
|
|
83
|
|
74
|
|
70
|
|
|
Weight management
|
|
203
|
|
181
|
|
120
|
|
|
|
|
3,367
|
|
2,865
|
|
2,509
|
|
|
Total net sales revenue
|
|
$
|
366,367
|
|
$
|
369,826
|
|
$
|
360,826
|
|
|
| Schedule of consolidated property, plant and equipment by geographical locations |
|
As of December 31
|
|
2014
|
|
2013
|
|
|
Property, plant and equipment
|
|
|
|
|
|
|
United States
|
|
$
|
48,013
|
|
$
|
25,713
|
|
|
Venezuela
|
|
—
|
|
3,207
|
|
|
Other
|
|
3,330
|
|
3,102
|
|
|
Total property, plant and equipment
|
|
$
|
51,343
|
|
$
|
32,022
|
|
|